Every year for Giving Tuesday, Alliance for Cancer Gene Therapy receives donations from people committed to solving cancer through the power of cell and gene therapy. Cell and gene therapy…
Cancer cell and gene therapy is an emerging type of treatment. We compiled a list of common questions and answers to empower you or a loved one. Cancer cell and…
https://www.youtube.com/watch?v=mMGsaw0W0lE…
https://www.youtube.com/watch?v=9-KNerTWgRs&authuser=0 With guidance from our Scientific Advisory Council and Board of Directors, the organization considers funding projects with robust scientific foundations and clearly defined paths to the clinic and the…
https://www.youtube.com/watch?v=lIumUed7ZPI With success in overcoming blood cancers established, our current funding priorities focus on new curative strategies for the most difficult-to-treat solid tumor cancers – glioblastoma, a brain cancer, and…
…T-cell therapy he hopes will achieve dramatic results. “There’s an old saying that I like,” says Powell. “All patients deserve an optimistic doctor.” https://www.youtube.com/watch?v=1xRSTH9IbsM Unlike traditional chemotherapy and radiation, Dr….
…brightest scientists. Please donate today to join our Alliance and help us win the fight against cancer. Page sources Penn Researchers Shorten Manufacturing Time for CAR T Cell Therapy. Penn…
…razor-sharp focus on raising money to fund solid tumor research projects and continuing an important new collaboration in cell therapy for brain cancer. Read the Latest Impact Report Meet…
…to the University of Madison Wisconsin for blood tests. Austin was supposed to be getting ready for his upcoming 3rd birthday party back at his home in Fall River, Wisconsin. …
…self-perpetuating p53 cancer therapy: Each time a virus homes in on a p53 mutant tumor cell and successfully replicates, the virus ultimately kills the cancer cell by bursting it open…
When Noriyuki Kasahara, MD, PhD, was a student in medical school, he watched his aunt lay in a coma for nearly a year, dying of glioblastoma. It was then that…
…that operates in compliance with current good laboratory practices. This group works seamlessly with the manufacturing team to generate clinical-grade T cells in compliance with current good manufacturing practice. Furthermore,…
Glioblastoma (GBM) is the most common malignant brain tumor in adults. It is incurable, with average patient survival of about 13 months even with an aggressive therapeutic regimen consisting of…
…T cells as a complementary immunotherapy to augment traditional treatment strategies. The engineered T cells eradicate large tumors in pre-clinical experiments. In this project, we will conduct FDA-mandated pre-clinical experiments,…
…need to develop new therapies. We propose to develop a therapy, called immunotherapy, which uses the patient’s own immune system to destroy their sarcoma. Immunotherapies comes in many different forms,…
…of time. We will test these T cells in animal models and translate these findings into human T cells as well. The goal is to generate super-soldier type T cells,…
…a novel bispecific molecule that we have designed and constructed in our laboratory, called ‘TanCAR’. We will further test the function of these bispecific T cells against melanoma cells in…
…tumor cells and kill them. In this grant, we will identify the optimal protocol to load various types of cell carriers with viruses and test them in animal models. In…
